Logo
ホームページ
当社のモデルを探求してください。
カート
連絡先
購読する
モデル製品
HUGOシリーズ 🌟
HUGO-GT™(ヒト化ゲノムオルソログ)
HUGO-Ab™(抗体開発)
HUGO-Mab™ – 完全ヒトモノクローナル抗体マウス
MouseAtlas モデルライブラリ
期間限定セール
研究用動物モデル
Creマウス系統
ヒト化ターゲット遺伝子モデル
代謝疾患モデル
眼科疾患モデル
神経疾患モデル
自己免疫疾患モデル
免疫不全マウスモデル
ヒト化免疫系マウスモデル
腫瘍学・免疫腫瘍学モデル
新型コロナウイルス感染症(Covid-19)用マウスモデル
細胞株モデル
ノックアウト細胞株製品カタログ
iPS細胞株製品カタログ
腫瘍細胞株製品カタログ
AAV 标準製品カタログ
サービス
前臨床薬効評価
神経科学
アルツハイマー病前臨床CROサービス
パーキンソン病前臨床CROサービス
ハンチントン病前臨床CROサービス
血液脳関門(BBB)研究ソリューション
眼科分野
緑内障前臨床CROサービス
加齢黄斑変性(AMD)前臨床CROサービス
がん研究
PBMCヒト化マウスモデル
ヒト免疫システム(HIS)マウスモデル
代謝・循環器系疾患
抗肥満薬開発向け前臨床CROサービス
自己免疫・炎症疾患
喘息前臨床CROサービス
遺伝子改変動物
ノックアウトマウス
トランスジェニックマウス
ノックインマウス
ノックアウトラット
ノックインラット
トランスジェニックラット
遺伝子改変モデルの作製技術
TurboknockoutTMゲノム標的化技術
ターゲティング遺伝子編集
通常型トランスジェニック
PiggyBacトランスジェネシス
BACトランスジェニック
ES細胞ターゲティング
繁殖・サポートサービス
繫殖サービス
凍結保存および回復
表型解析サービス
BAC改変
ウイルスパッケージング
アデノ関連ウイルス(AAV)パッケージング
レントウイルスパッケージング
アデノウイルスパッケージング
カスタム細胞株作製サービス
誘導多能性幹細胞(iPS細胞)
ノックアウト細胞株
ノックイン細胞株
点変異細胞株
過剰発現細胞株
モダリティ
遺伝子治療
AI駆動型AAV開発
核酸医薬
細胞免疫療法
コミュ二ティー
キャンペーン
イベント・ウェビナー
ニュース
研究情報
資料室
データベース
査読済み文献(引用)
希少疾患データセンター
AbSeek
Cell iGeneEditor™ システム
OriCell 細胞培養関連
会社案内
企業概要
施設概要
動物の健康・福祉
健康報告書
協力企業・代理店
採用情報
お問い合わせ
Login
フィルター
フィルター
KO/cKO マウスモデル
フラッシュセール
HUGO-GT™ プラットフォーム
ヒト化ターゲット遺伝子モデル
ヒト化ターゲット遺伝子モデル
免疫ターゲットヒト化モデル腫瘍ターゲットヒト化モデル代謝ターゲットヒト化モデルサイトカインヒト化モデルその他のターゲットヒト化モデル
免疫系マウスモデル
免疫不全マウスモデルヒト化免疫系モデル
遺伝学ツールマウスモデル
Creドライバー系統レポーターマウス系統その他の遺伝学ツール系統
専門疾患モデル
眼科疾患モデル神経疾患モデル代謝疾患モデル腫瘍学・免疫腫瘍学モデル自己免疫疾患モデル希少疾患モデル感染症疾患モデルその他の疾患モデル
4 件の結果が “5972” で取得されました
フィルター
並べ替える:
アルファベット順(A-Z)
ベストセラー
SD-H11-hREN
製品ID :
CR009
系統:
SD
状況:
Live Mouse
説明:
The REN gene encodes renin, a crucial aspartyl protease and the rate-limiting enzyme of the renin-angiotensin system (RAS), which is fundamental for regulating blood pressure and electrolyte balance [1]. Primarily expressed in the juxtaglomerular cells of the kidneys, renin is secreted into the bloodstream where it functions to cleave angiotensinogen, produced by the liver, into angiotensin I [2]. This initiates a cascade leading to the formation of angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release from the adrenal glands, ultimately increasing blood pressure and sodium retention [3]. Mutations in the REN gene have been linked to several renal disorders, including familial juvenile hyperuricemic nephropathy type II, familial hyperreninemia, and renal tubular dysgenesis [4]. SD-H11-hREN rats are a humanized model generated using gene editing technology, in which the “3 kb of 5’- flanking sequence-Human REN DNA-1.2 kb of 3'-flanking sequence” cassette was inserted into H11 locus. Homozygous SD-H11-hREN rats are viable and fertile. This model can be used for research on the regulation of blood pressure, body fluid, and electrolyte homeostasis, as well as for studying the pathogenic mechanisms and drug development for various hereditary kidney diseases such as renal tubular dysgenesis and familial hyperreninemia.
The REN gene encodes renin, a crucial aspartyl protease and the rate-limiting enzyme of the renin-angiotensin system (RAS), which is fundamental for regulating blood pressure and electrolyte balance [1]. Primarily expressed in the juxtaglomerular cells of the kidneys, renin is secreted into the bloodstream where it functions to cleave angiotensinogen, produced by the liver, into angiotensin I [2]. This initiates a cascade leading to the formation of angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release from the adrenal glands, ultimately increasing blood pressure and sodium retention [3]. Mutations in the REN gene have been linked to several renal disorders, including familial juvenile hyperuricemic nephropathy type II, familial hyperreninemia, and renal tubular dysgenesis [4]. SD-H11-hREN rats are a humanized model generated using gene editing technology, in which the “3 kb of 5’- flanking sequence-Human REN DNA-1.2 kb of 3'-flanking sequence” cassette was inserted into H11 locus. Homozygous SD-H11-hREN rats are viable and fertile. This model can be used for research on the regulation of blood pressure, body fluid, and electrolyte homeostasis, as well as for studying the pathogenic mechanisms and drug development for various hereditary kidney diseases such as renal tubular dysgenesis and familial hyperreninemia.
SD-Rosa-hAGT/H11-hREN
製品ID :
CR007
系統:
SD
状況:
Live Mouse
説明:
The AGT gene encodes the precursor of angiotensinogen, primarily expressed in the liver. It serves as a rate-limiting substrate in the renin-angiotensin system (RAS). When blood pressure decreases, the angiotensinogen precursor is cleaved by renin to generate angiotensin I (Ang I) in response. Subsequently, Ang I is further processed by angiotensin-converting enzyme (ACE) to produce the physiologically active enzyme angiotensin II (Ang II), which regulates blood pressure [1]. This protein is involved in maintaining blood pressure, body fluid, and electrolyte homeostasis, and plays a role in the pathogenesis of primary hypertension and preeclampsia [2-3]. Mutations in the AGT gene are closely associated with susceptibility to primary hypertension and can lead to renal tubular dysplasia [4]. Additionally, defects in this gene are associated with non-familial structural atrial fibrillation and inflammatory bowel disease [5]. The REN gene encodes renin, another integral component of the RAS, which is fundamental for regulating blood pressure and electrolyte balance [6]. Primarily expressed in the juxtaglomerular cells of the kidneys, renin is secreted into the bloodstream where it functions to cleave angiotensinogen, produced by the liver, into angiotensin I [7]. This initiates a cascade leading to the formation of angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release from the adrenal glands, ultimately increasing blood pressure and sodium retention [8]. Mutations in the REN gene have been linked to several renal disorders, including familial juvenile hyperuricemic nephropathy type II, familial hyperreninemia, and renal tubular dysgenesis [9]. The SD-Rosa-hAGT/H11-hREN rats are a humanized model obtained by mating SD-Rosa-hAGT rats with SD-H11-hREN rats. This model can be used for research on the regulation of blood pressure, body fluid and electrolyte homeostasis, and the pathological mechanisms and treatment methods of primary hypertension, preeclampsia, renal tubular hypoplasia, non-familial structural atrial fibrillation, inflammatory bowel disease, etc. Moreover, it can be applied to the development of antihypertensive drugs targeting the renin-angiotensin system (RAS).
The AGT gene encodes the precursor of angiotensinogen, primarily expressed in the liver. It serves as a rate-limiting substrate in the renin-angiotensin system (RAS). When blood pressure decreases, the angiotensinogen precursor is cleaved by renin to generate angiotensin I (Ang I) in response. Subsequently, Ang I is further processed by angiotensin-converting enzyme (ACE) to produce the physiologically active enzyme angiotensin II (Ang II), which regulates blood pressure [1]. This protein is involved in maintaining blood pressure, body fluid, and electrolyte homeostasis, and plays a role in the pathogenesis of primary hypertension and preeclampsia [2-3]. Mutations in the AGT gene are closely associated with susceptibility to primary hypertension and can lead to renal tubular dysplasia [4]. Additionally, defects in this gene are associated with non-familial structural atrial fibrillation and inflammatory bowel disease [5]. The REN gene encodes renin, another integral component of the RAS, which is fundamental for regulating blood pressure and electrolyte balance [6]. Primarily expressed in the juxtaglomerular cells of the kidneys, renin is secreted into the bloodstream where it functions to cleave angiotensinogen, produced by the liver, into angiotensin I [7]. This initiates a cascade leading to the formation of angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release from the adrenal glands, ultimately increasing blood pressure and sodium retention [8]. Mutations in the REN gene have been linked to several renal disorders, including familial juvenile hyperuricemic nephropathy type II, familial hyperreninemia, and renal tubular dysgenesis [9]. The SD-Rosa-hAGT/H11-hREN rats are a humanized model obtained by mating SD-Rosa-hAGT rats with SD-H11-hREN rats. This model can be used for research on the regulation of blood pressure, body fluid and electrolyte homeostasis, and the pathological mechanisms and treatment methods of primary hypertension, preeclampsia, renal tubular hypoplasia, non-familial structural atrial fibrillation, inflammatory bowel disease, etc. Moreover, it can be applied to the development of antihypertensive drugs targeting the renin-angiotensin system (RAS).
Abhd17a-flox
製品ID :
S-CKO-05972
系統:
C57BL/6JCya
状況:
Research and Development
説明:
Abhd17a is located on chromosome 10 of mice. SgRNA and ssDNA will be designed using Nuclease Technology; Abhd17a conditional knockout mice will be obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm will be collected for cryopreservation.
Abhd17a is located on chromosome 10 of mice. SgRNA and ssDNA will be designed using Nuclease Technology; Abhd17a conditional knockout mice will be obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm will be collected for cryopreservation.
R3hdm1-KO
製品ID :
S-KO-05972
系統:
C57BL/6JCya
状況:
Research and Development
説明:
R3hdm1 is located on chromosome 1 of mice. Nuclease Technology will be used to design sgRNA; R3hdm1 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
R3hdm1 is located on chromosome 1 of mice. Nuclease Technology will be used to design sgRNA; R3hdm1 knockout mice will be obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Items: 1 to 4 of 4
1
さらに
すべてのフィルター
Strain Type
Mouse
Rat
Modification Type
Knockout
Conditional Knockout
Knockin
Point Mutation
Transgenic
Conditional Knockin
Others
Status
Live Mice
R&D
Frozen Sperm
Validation Data
Verified
In Progress
リセット
確認する
モデルライブラリ
モデルライブラリ
リソース
リソース
動物の品質
動物の品質
サポートを受ける
サポートを受ける
住所:
〒543-0071 大阪府大阪市天王寺区生玉町2-3 小出ビル410室
電話 :
06-7652-3321
メール:
[email protected]
モデル製品
HUGO-Ab™(抗体開発)HUGO-GT™(ヒト化ゲノムオルソログ)MouseAtlas モデルライブラリ研究用動物モデル
サービス
神経科学眼科分野がん研究代謝・循環器系疾患自己免疫・炎症疾患
会社案内
企業概要施設概要動物の健康・福祉健康報告書協力企業・代理店採用情報お問い合わせ
SNS
免責事項:当社の製品およびサービスの価格や入手可能性は地域によって異なります。記載されている価格は特定の国々に適用されます。詳細についてはご連絡ください。
Copyright © 2025 Cyagen. All rights reserved.
プライバシーポリシー
サイトマップ
Cyagenの最新情報をお届けします
研究モデル、CROサービス、科学リソース、特別オファーに関する最新情報を、研究ニーズに合わせてメールでお届けします。
お名前
メール
ご所属機関
関心分野
主な研究分野